These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36922032)

  • 1. Efficacy and safety of low dose intravenous cangrelor in a consecutive cohort of patients undergoing neuroendovascular procedures.
    Cagnazzo F; Radu RA; Derraz I; Lefevre PH; Dargazanli C; Machi P; Morganti R; Gascou G; Fendeleur J; Rapido F; Costalat V
    J Neurointerv Surg; 2023 Dec; 16(1):88-93. PubMed ID: 36922032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cangrelor dose titration using platelet function testing during cerebrovascular stent placement.
    Entezami P; Holden DN; Boulos AS; Paul AR; Field NC; Nourollahzadeh E; Yamamoto J; Dalfino JC
    Interv Neuroradiol; 2021 Feb; 27(1):88-98. PubMed ID: 32611215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study.
    Aguilar-Salinas P; Agnoletto GJ; Brasiliense LBC; Santos R; Granja MF; Gonsales D; Aghaebrahim A; Sauvageau E; Hanel RA
    J Neurointerv Surg; 2019 Apr; 11(4):347-351. PubMed ID: 30552167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary Experience with Cangrelor for Endovascular Treatment of Challenging Intracranial Aneurysms.
    Abdennour L; Sourour N; Drir M; Premat K; Shotar E; Taylor G; Godier A; Mathout J; Lenck S; Bernard R; Carpentier A; Degos V; Clarençon F
    Clin Neuroradiol; 2020 Sep; 30(3):453-461. PubMed ID: 31309241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cangrelor and Stenting in Acute Ischemic Stroke : Monocentric Case Series.
    Elhorany M; Lenck S; Degos V; Sourour NA; Frasca Polara G; Shotar E; Godier A; Drir M; Mahtout J; Premat K; Alamowitch S; Samson Y; Clarençon F
    Clin Neuroradiol; 2021 Jun; 31(2):439-448. PubMed ID: 32382875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series.
    Bowman S; Gass J; Weeks P
    Ann Pharmacother; 2019 Feb; 53(2):171-177. PubMed ID: 30132336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of antiplatelet response to low-dose cangrelor utilizing platelet function testing in neuroendovascular patients.
    Holden DN; Entezami P; Bush MC; Field NC; Paul AR; Boulos AS; Yamamoto J; Dalfino JC
    Pharmacotherapy; 2021 Oct; 41(10):811-819. PubMed ID: 34496076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.
    Angiolillo DJ; Firstenberg MS; Price MJ; Tummala PE; Hutyra M; Welsby IJ; Voeltz MD; Chandna H; Ramaiah C; Brtko M; Cannon L; Dyke C; Liu T; Montalescot G; Manoukian SV; Prats J; Topol EJ;
    JAMA; 2012 Jan; 307(3):265-74. PubMed ID: 22253393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous cangrelor in the treatment of ruptured and unruptured cerebral aneurysms: an updated single-center analysis and pooled analysis of current studies.
    Entezami P; Dalfino JC; Boulos AS; Yamamoto J; Holden DN; Field NC; Rock AK; Najera E; Paul AR
    J Neurointerv Surg; 2023 Jul; 15(7):669-673. PubMed ID: 35732485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials.
    Vaduganathan M; Harrington RA; Stone GW; Deliargyris EN; Steg PG; Gibson CM; Hamm CW; Price MJ; Menozzi A; Prats J; Elkin S; Mahaffey KW; White HD; Bhatt DL
    JAMA Cardiol; 2017 Feb; 2(2):127-135. PubMed ID: 27902833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cangrelor in neurovascular interventions: a multicenter experience.
    Cortez GM; Monteiro A; Sourour N; Clarençon F; Elhorany M; Grigoryan M; Mirza S; Dabus G; Linfante I; Aguilar-Salinas P; Murtaza Y; Aghaebrahim A; Sauvageau E; Hanel RA
    Neuroradiology; 2021 Jun; 63(6):925-934. PubMed ID: 33174182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Low Dose Intravenous Cangrelor in Acute Ischemic Stroke: A Case Series.
    Salahuddin H; Dawod G; Zaidi SF; Shawver J; Burgess R; Jumaa MA
    Front Neurol; 2021; 12():636682. PubMed ID: 34149590
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.
    Gutierrez JA; Harrington RA; Blankenship JC; Stone GW; Steg PG; Gibson CM; Hamm CW; Price MJ; Généreux P; Prats J; Deliargyris EN; Mahaffey KW; White HD; Bhatt DL;
    Eur Heart J; 2016 Apr; 37(14):1122-30. PubMed ID: 26400827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Cangrelor Use After Percutaneous Coronary Intervention in Patients With Mechanical Circulatory Support.
    Pluenneke JC; Mohamed AM; Hayes CH; Berry TP; Thomas EL; Zhurav L; Kozinn JB; Haines MM; Welge JA
    J Cardiothorac Vasc Anesth; 2023 Dec; 37(12):2511-2516. PubMed ID: 37775345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous cangrelor and oral ticagrelor as an alternative to clopidogrel in acute intervention.
    Linfante I; Ravipati K; Starosciak AK; Reyes D; Dabus G
    J Neurointerv Surg; 2021 Jan; 13(1):30-32. PubMed ID: 32414891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
    Kirtane AJ; Parikh PB; Stuckey TD; Xu K; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Parvataneni R; Maehara A; Généreux P; Mehran R; Stone GW
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1978-1987. PubMed ID: 26738669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Cangrelor in Cervical and Intracranial Stenting for the Treatment of Acute Ischemic Stroke: A "Real Life" Single-Center Experience.
    Cervo A; Ferrari F; Barchetti G; Quilici L; Piano M; Boccardi E; Pero G
    AJNR Am J Neuroradiol; 2020 Nov; 41(11):2094-2099. PubMed ID: 33033047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION.
    Peterson BE; Harrington RA; Stone GW; Steg PG; Gibson CM; Hamm CW; Price MJ; Lopes RD; Leonardi S; Prats J; Deliargyris EN; Mahaffey KW; White HD; Bhatt DL
    Circ Cardiovasc Interv; 2022 Mar; 15(3):e011069. PubMed ID: 35196863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Franchi F; Rollini F; Rivas A; Wali M; Briceno M; Agarwal M; Shaikh Z; Nawaz A; Silva G; Been L; Smairat R; Kaufman M; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
    Circulation; 2019 Apr; 139(14):1661-1670. PubMed ID: 30630341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
    Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.